Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Remote Controlled Drug Delivery (Deadline: 20 June 2020)
- Advances on Chelation in Medicine (Deadline: 30 June 2020)
- Progress in the Molecular Characterization of Prostate Cancer: Implications for the Identification of Novel Biomarkers and Therapeutic Targets (Deadline: 30 June 2020)
- Oxidative Stress in Hypertension: Mechanisms and Potential Pharmacological Targets (Deadline: 30 June 2020)
- Adenovirus: Enduring Toolbox for Basic and Applied Research (Deadline: 30 June 2020)
- Targeting Monoamine Oxidases: From Enzymatic Function to Pharmaceutical Use (Deadline: 30 June 2020)
- Drug Repurposing for Neglected Disorders: Rare Neurodevelopmental Conditions (Deadline: 31 July 2020)
- Ionic Liquids in Drug Development, Formulation, and Delivery (Deadline: 31 July 2020)
- Nitric Oxide: Physiology, Pharmacology, and Therapeutic Applications (Deadline: 31 July 2020)
- GRKs and Arrestins in Human Health and Disease (Deadline: 31 July 2020)
- Protein–Ligand Interactions: Deciphering the Molecular Targets and the Mechanisms of Action of Drugs and Natural Compounds 2.0 (Deadline: 31 August 2020)
- Pharmacogenomics (Deadline: 31 August 2020)
- Bioactive Oxadiazoles (Deadline: 31 August 2020)
- Biological Activities and Biomedical Application of Isatin and Its Analogues (Deadline: 31 August 2020)
- Structure–Activity Studies of Antibacterials and Potentiators of Antibiotics (Deadline: 31 August 2020)
- How the AHR Became Important-A Lesson in How Basic Science Leads to Actionable Translational Medicine (Deadline: 15 September 2020)
- Advances in Nanostructured Materials between Pharmaceutics and Biomedicine (Deadline: 30 September 2020)
- Inhibition of DNA Repair Enzymes as a Valuable Pharmaceutical Approach (Deadline: 30 September 2020)
- Mechanistic Effects of Human Variants Associated with Addiction (Deadline: 30 September 2020)
- Mechanisms of Antipsychotic Action: From the Researcher Bench to the Patient Bedside (Deadline: 30 September 2020)
- Pharmacogenetics and Personalized Medicine 2.0 (Deadline: 30 September 2020)
- Drug Transporters (Deadline: 20 October 2020)
- Tissue-Specific Direct and Indirect Effects of Metformin and Its Application (Deadline: 30 October 2020)
- The Therapeutic Approach of Natural Products in Risk Factors of Cardiovascular Disease (Deadline: 31 October 2020)
- Lipid-Based Drug Carriers and Nanoparticles (Deadline: 31 October 2020)
- Natural and Synthetic Lactones: Isolation, Synthesis, Biotransformations and Biological Activity (Deadline: 30 November 2020)
- Disease, Ageing and Cancer Prevention by Natural Products (Deadline: 30 November 2020)
- Modulation of Oxidative Stress: Molecular and Pharmacological Aspects 2.0 (Deadline: 22 December 2020)
- Therapeutic Modulation of Mesenchymal Stem Cells for Effective Regenerative Medicine (Deadline: 30 December 2020)
- Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression (Deadline: 31 December 2020)
- The Diversity of Mammalian Nod-Like Receptor Functions (Deadline: 31 December 2020)
- Artificial Intelligence and Machine Learning in Drug Development (Deadline: 31 December 2020)
- Cytotoxic Drugs in the Modern Era of Personalized Medicine: Are They Still of Value? (Deadline: 31 December 2020)
- Molecular Mechanisms of Mood Stabilizers (Deadline: 31 December 2020)
- Advance in Drug-Drug Interactions (Deadline: 31 December 2020)
- Cannabidiol: New Vistas of its Molecular Mechanisms, Biological Effects and Therapeutic Application (Deadline: 31 December 2020)
- Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk (Deadline: 31 January 2021)
- COVID-19 Innovative Drug Treatments: Looking Outside of Plato’s Cave (Deadline: 31 January 2021)
- Curcumin Derivatives and Curcuminoids as Theranostic Agents in Alzheimer’s Disease (Deadline: 28 February 2021)
Topical Collections
Following topical collections within this section are currently open for submissions:
